Immucell Corp
Research Immucell Corp (ICCC) on Bullrun: market cap USD 89.65M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerICCC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 89.65M
- Financial periodFY2025
- RevenueUSD 27.64M
- Revenue growth4.3%
- Net income-USD 1.04M
- Free cash flowUSD 1.22M
- Gross margin41.4%
Valuation Snapshot
latest market cap is USD 89.65M.
About Immucell Corp
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus.
Frequently asked questions
What is Immucell Corp's market cap?
Immucell Corp's market capitalization is USD 89.65M.
What does Immucell Corp do?
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis.